Comment on: Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin
J Antimicrob Chemother
.
2009 Dec;64(6):1347.
doi: 10.1093/jac/dkp379.
Epub 2009 Oct 19.
Authors
Niels Adriaenssens
,
Herman Goossens
,
Samuel Coenen
;
ESAC Project Group
PMID:
19841030
DOI:
10.1093/jac/dkp379
No abstract available
Publication types
Comment
Letter
MeSH terms
Anti-Bacterial Agents / therapeutic use*
Bacterial Infections / drug therapy*
Daptomycin / therapeutic use*
Europe
Humans
Outpatients
Substances
Anti-Bacterial Agents
Daptomycin